About Shilpa Therapeutics
Shilpa Therapeutics is a Healthcare company based in Hyderabad (India) founded in 2005 by Venkatesh Katakam and Vishnukant Bhutada. It develops innovative technologies for orally disintegrating strips in pharmaceuticals. It operates on a B2B model. The company has 24 employees. Its chief executive, as recorded, is Venkatesh Katakam. Its Indian entity Shilpa Therapeutics Private Limited reported revenue of ₹4.45 Cr. Its focus areas include Pharmaceuticals, Drug Delivery Systems and Oral Disintegrating Technologies. Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Shilpa Therapeutics develops innovative technologies for orally disintegrating strips in pharmaceuticals through providing healthcare solutions, producing pharmaceutical products, drug delivery systems, and oral disintegrating technologies. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Hyderabad, India
- Employees 24
- Founders Venkatesh Katakam, Vishnukant Bhutada
- SectorsHealthcare
- Website shilpatherapeutics.com
- Legal Name Shilpa Therapeutics Private Limited
- Date of Incorporation 02 Apr, 2004
- Jurisdiction Raichur, Karnataka, India
- Annual Revenue₹4.45 Cr
FY 2023 · -34% YoY
- Net Loss-₹7.93 Cr
FY 2023 · -178% margin
- EBITDA-₹3.23 Cr
FY 2023 · -73% margin
- Employee Count24
Associated legal entities of Shilpa Therapeutics
Shilpa Therapeutics is associated with 2 registered companies on The Company Check; the primary company is Shilpa Therapeutics Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shilpa Therapeutics Private Limited CIN U24239KA2004PTC176079 | Active | 02 Apr 2004 | Raichur, Karnataka | ₹4.4 Cr | 24 | 2 | View details |
| Shilpa Medicare Limited Listed CIN L85110KA1987PLC008739 | Active | 20 Nov 1987 | Raichur, Karnataka | ₹1,603 Cr | 930 | 8 | View details |
Board of directors of Shilpa Therapeutics Private Limited (Shilpa Therapeutics)
Shilpa Therapeutics Private Limited is the primary company behind Shilpa Therapeutics. The boards of the 2 registered companies of Shilpa Therapeutics currently have 7 directors; the longest-serving is Om Prakash Inani, appointed in 1988. 35 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Om Prakash Inani DIN 01301385 | Director | 23 Mar 1988 | 38 yrs 7 mo | Shilpa Medicare Limited |
| Ramakant Innani DIN 03222748 | Director | 07 Sep 2011 | 15 yrs 2 mo | Shilpa Therapeutics Private Limited |
| Vishnukanth Chaturbhuj Bhutada DIN 01243391 | Managing Director | 01 Sep 2015 | 11 yrs 2 mo | Shilpa Medicare Limited, Shilpa Therapeutics Private Limited |
| Kalakota Reddy Sharath DIN 03603460 | Whole-time director | 01 Oct 2019 | 7 yrs 1 mo | Shilpa Medicare Limited |
| Hetal Madhukant Gandhi DIN 00106895 | Director | 02 Sep 2021 | 5 yrs 2 mo | Shilpa Medicare Limited |
| Anita Bandyopadhyay DIN 08672071 | Director | 11 Aug 2022 | 4 yrs 3 mo | Shilpa Medicare Limited |
| Ashraf Loutfy Abdelhamid Allam DIN 11192531 | Director | 13 Aug 2025 | 1 yr 3 mo | Shilpa Medicare Limited |
People of Shilpa Therapeutics
2 people are tracked at Shilpa Therapeutics (2 in leadership); the tracked headcount is 24.
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO | Leadership | |
Vishnukant Bhutada | Co-Founder, Managing Director | Leadership |
Complete people profiles for Shilpa Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Shilpa Therapeutics
Figures of Shilpa Therapeutics Private Limited, the primary company behind Shilpa Therapeutics, for FY 2023. Revenue was ₹4.45 Cr (-34% year on year). Net loss was -₹7.93 Cr (-178% margin). EBITDA was -₹3.23 Cr (-73% margin). Revenue has grown at a compounded annual rate of +7% over five years.
- ₹4.45 CrRevenue · FY 2023 · -34% YoY
- -₹7.93 CrNet loss · -178% margin
- -₹3.23 CrEBITDA · -73% margin
- ₹2.24 CrPaid-up capital
- 24Employees (provident fund records)
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Shilpa Therapeutics Private Limited are on its company page.
Detailed financial statements for Shilpa Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Shilpa Therapeutics
Shilpa Therapeutics has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. |
Detailed competitors of Shilpa Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Shilpa Therapeutics
Complete news archive for Shilpa Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shilpa Therapeutics
Shilpa Therapeutics was founded in 2005.
Shilpa Therapeutics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Venkatesh Katakam is the CEO of Shilpa Therapeutics, as recorded in our data. They have also founded this company.
Shilpa Therapeutics has 24 employees.
The primary company behind Shilpa Therapeutics, Shilpa Therapeutics Private Limited, reported revenue of ₹4.45 Cr for FY 2023, down 34% year on year.
Shilpa Therapeutics develops innovative technologies for orally disintegrating strips in pharmaceuticals through providing healthcare solutions, producing pharmaceutical products, drug delivery systems, and oral disintegrating technologies. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Shilpa Therapeutics's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.
Shilpa Therapeutics is associated with 2 legal entities: Shilpa Therapeutics Private Limited, Shilpa Medicare Limited.
The legal entities of Shilpa Therapeutics currently have 9 directors, including Om Prakash Inani, Kalakota Reddy Sharath, Alpesh Maheshkumar Dalal and others.